Clofoctol
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Clofoctol is a bacteriostatic antibiotic. It is used in the treatment of respiratory tract and ear, nose and throat infections caused by Gram-positive bacteria.[1] It is marketed in France under the trade name Octoplus and in Italy as Gramplus.
It is only functional against Gram-positive bacteria.[2]
It penetrates into human lung tissue.[3]
References
- ↑ 1.0 1.1 1.2 1.3 1.4 “Gramplus” (in Italian). Studio Medico Torrino. July 25, 2007. Retrieved 2007-08-10.
- ↑ Combe J, Simonnet F, Yablonsky F, Simonnet G (1980). “[Clofoctol binding by the bacteria (author’s transl)]”. J Pharmacol (in French). 11 (4): 411–25. PMID 6782374.
- ↑ Danesi R, Gasperini M, Senesi S, Freer G, Angeletti CA, Del Tacca M (1988). “A pharmacokinetic study of clofoctol in human plasma and lung tissue by using a microbiological assay”. Drugs Exp Clin Res. 14 (1): 39–43. PMID 3391105.
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH